Studies | EBMT

Top

Study type

Disease

Group

Type of transplant / Cell therapy

Text

Language

Second malignancies after SCT for Hypodiploid ALL: TP53 mutation

Closed Survey/Study

Acute Lymphatic Leukaemia (ALL)

Paediatric Diseases Working Party (PDWP)

Type of treatment

Principal investigator

Laura Bettini (Monza)

ALL study, patients transplanted between 2 and 4 years old

Retrospective Studies

Acute Lymphatic Leukaemia (ALL)

Paediatric Diseases Working Party (PDWP)

Type of treatment

Principal investigator

Krzysztof Kalwak

Use of Letermovir after transplant in pediatric patients

Retrospective Studies

Paediatric Diseases Working Party (PDWP)

Type of treatment

Principal investigator

Giovanna Lucchini (London)

Impact of Donor and Patient CMV Serology for malignant

Retrospective Studies

Acute Myeloid Leukaemia (AML)

Acute Lymphatic Leukaemia (ALL)

Chronic Myeloid Leukaemia (CML)

Other myeloid or lymphoid malignancies

Paediatric Diseases Working Party (PDWP)

Type of treatment

Principal investigator

Elif Ince (Ankara)

Impact of the acute GVH on outcomes in ALL

Retrospective Studies

Acute Lymphatic Leukaemia (ALL)

Paediatric Diseases Working Party (PDWP)

Type of treatment

Principal investigator

Giovanna Lucchini (London)

Evaluating the Impact of ABO Compatibility on Allogeneic Stem Cell Transplantation Outcomes

Retrospective Studies

Transplant Complications Working Party (TCWP)

Type of treatment

Principal investigator

Survey on the use of DLI after allogeneic after allogeneic stem cell transplantation across EBMT centers

Closed Survey/Study

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type of treatment

Donor Leukocyte Infusion (DLI)

Principal investigator

Outcome of transplant in PNH patients treated after 2011

Retrospective Studies

Bone marrow failure

Severe Aplastic Anaemia Working Party (SAAWP)

Type of treatment

Principal investigator

Résultats de la greffe chez les patients atteints d'aplasie médullaire sévère (SAA) âgés de plus de 40 ans et traités après 2010

Études rétrospectives

Aplasie Médullaire

Severe Aplastic Anaemia Working Party (SAAWP)

Type of treatment

Principal investigator

Antonio Risitano

Transplant outcomes in patients over 40 years old with severe aplastic anemia (SAA) treated after 2010

Retrospective Studies

Bone marrow failure

Severe Aplastic Anaemia Working Party (SAAWP)

Type of treatment

Principal investigator

Antonio Risitano

Allogeneic Hematopoietic Stem Cell Transplantation for ERCC6L2 disease

Closed Survey/Study

Bone marrow failure

Severe Aplastic Anaemia Working Party (SAAWP)

Type of treatment

Principal investigator

Ulla Wartiovaara-Kautto, Outi Kilpivaara and Flore Sicre de Fontbrune

Allogeneic HSCT in ICU setting

Closed Survey/Study

Bone marrow failure

Severe Aplastic Anaemia Working Party (SAAWP)

Type of treatment

Principal investigator

Tayfun Güngör